Connection
Frits Van Rhee to Models, Biological
This is a "connection" page, showing publications Frits Van Rhee has written about Models, Biological.
|
|
Connection Strength |
|
 |
|
 |
|
0.147 |
|
|
|
-
Morra DE, Pierson SK, Shilling D, Nemat S, Appiani C, Guilfoyle M, Tendler C, van Rhee F, Fajgenbaum DC. Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data. Br J Haematol. 2019 01; 184(2):232-241.
Score: 0.124
-
Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014 May 08; 123(19):2924-33.
Score: 0.023